flow trial semaglutide nejm could be 'practice changing' for adults with diabetes, CKD In the FLOW trial, researchers

10.3390/ijerph17041191 [DOI] [PMC free article] [PubMed] [Google Scholar] 76.Gould GS, Hurst JR, Trofor A, Alison JA, Fox G, Kulkarni MM, et al

Animal studies have suggested that GLP-1 receptors are expressed in various brain regions, including areas involved in stress response regulation

Twenty-four sites associated with ECOG accrued patients for the study

, GLP-1 RA

Detoxification Support: Aids in the detoxification of the liver and kidneys, supporting the bodys ability to eliminate toxins and harmful substances

Recognizing this potential, the FDA approved a higher-dose formulation under the brand name Wegovy specifically for chronic weight management, indicated for clients meeting certain Body Mass Index (BMI) criteria